This preview shows pages 1–3. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: Chem 130A: Pharmaceutical Chemistry Winter 2007 P P r r a a c c t t i i c c e e F F i i n n a a l l E E x x a a m m _______________________________ print your name here _______________________________ sign your name here • A f t e r y o u a r e t o l d t o b e g i n, please write your name on each page. • You have 120 minutes to complete the exam—manage your time accordingly. • Remember, an ambiguous answer is a wrong answer. • If you open the exam before you are told to do so, y o u w i l l l o s e 1 p o i n t s. • If you write on your examination after time is called, y o u w i l l l o s e 1 p o i n t s. • If you have to be asked to stop writing, y o u w i l l l o s e a n a d d i t i o n a l 1 p o i n t s. /200 total /25 /20 /15 #7 #8 #6 /20 /30 /35 #2 #3 #1 /30 #5 /25 #4 (1) (35 points total) Shown below is posaconazole, an antifungal drug that was approved by the FDA in September, 2006. Chem 130A, Winter 2007, Practice Final _______________________________ name (a) (5 points) Please label all good hydrogen-bond acceptors in posaconazole. (b) (5 points) Please label all good hydrogen-bond donors in posaconazole....
View Full Document
This note was uploaded on 10/22/2010 for the course CHE 130A taught by Professor Hague during the Winter '07 term at UC Davis.
- Winter '07